Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark G Thompson

Showing results (91-100 of 145) with videos related to

Pageof 15
Sort By:
Nature Communications|January 4, 2024
Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccinesFeng Liu, F Liaini Gross, Sneha Joshi, et al.
Reproductive Health|September 23, 2018
The Pregnancy and Influenza Multinational Epidemiologic (PRIME) study: a prospective cohort study of the impact of influenza during pregnancy among women in middle-income countriesFatimah S Dawood, Danielle Hunt, Archana Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2025
Enhanced Influenza Vaccines Extend A(H3N2) Antibody Reactivity in Older Adults but Prior Vaccination Effects PersistAnnette Fox, Stephany Sánchez-Ovando, Louise Carolan, et al.
Journal of Community Health|December 8, 2023
Vaccine Effectiveness Against SARS-CoV-2 Related Hospitalizations in People who had Experienced Homelessness or Incarceration - Findings from the Minnesota EHR ConsortiumMalini B DeSilva, Gregory Knowlton, Nayanjot K Rai, et al.
Vaccine|May 11, 2020
Intent to obtain pediatric influenza vaccine among mothers in four middle income countriesAbram L Wagner, Aubree Gordon, Veronica L Tallo, et al.
The Journal of Infectious Diseases|November 11, 2023
Influenza A(H3N2) Antibody Responses to Standard-Dose Versus Enhanced Influenza Vaccine Immunogenicity in Older Adults and Prior Season's Vaccine StatusShuyi Zhong, Tiffany W Y Ng, Danuta M Skowronski, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 12, 2024
Randomised immunogenicity trial comparing 2019-2020 recombinant and egg-based influenza vaccines among frequently vaccinated healthcare personnel in IsraelAshley L Fowlkes, Alon Peretz, David Greenberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2022
Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label TrialManjusha Gaglani, Sara S Kim, Allison L Naleway, et al.
Vaccine|June 16, 2022
Vaccine-associated attenuation of subjective severity among outpatients with influenzaJessie R Chung, Sara S Kim, Brendan Flannery, et al.
Open Forum Infectious Diseases|June 12, 2023
Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture-Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18-65 Years in 2019-2020Allison L Naleway, Sara S Kim, Brendan Flannery, et al.
Pageof 15

Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
Nature Communications|January 4, 2024
Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccinesFeng Liu, F Liaini Gross, Sneha Joshi, et al.
Reproductive Health|September 23, 2018
The Pregnancy and Influenza Multinational Epidemiologic (PRIME) study: a prospective cohort study of the impact of influenza during pregnancy among women in middle-income countriesFatimah S Dawood, Danielle Hunt, Archana Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2025
Enhanced Influenza Vaccines Extend A(H3N2) Antibody Reactivity in Older Adults but Prior Vaccination Effects PersistAnnette Fox, Stephany Sánchez-Ovando, Louise Carolan, et al.
Journal of Community Health|December 8, 2023
Vaccine Effectiveness Against SARS-CoV-2 Related Hospitalizations in People who had Experienced Homelessness or Incarceration - Findings from the Minnesota EHR ConsortiumMalini B DeSilva, Gregory Knowlton, Nayanjot K Rai, et al.
Vaccine|May 11, 2020
Intent to obtain pediatric influenza vaccine among mothers in four middle income countriesAbram L Wagner, Aubree Gordon, Veronica L Tallo, et al.
The Journal of Infectious Diseases|November 11, 2023
Influenza A(H3N2) Antibody Responses to Standard-Dose Versus Enhanced Influenza Vaccine Immunogenicity in Older Adults and Prior Season's Vaccine StatusShuyi Zhong, Tiffany W Y Ng, Danuta M Skowronski, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 12, 2024
Randomised immunogenicity trial comparing 2019-2020 recombinant and egg-based influenza vaccines among frequently vaccinated healthcare personnel in IsraelAshley L Fowlkes, Alon Peretz, David Greenberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2022
Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label TrialManjusha Gaglani, Sara S Kim, Allison L Naleway, et al.
Vaccine|June 16, 2022
Vaccine-associated attenuation of subjective severity among outpatients with influenzaJessie R Chung, Sara S Kim, Brendan Flannery, et al.
Open Forum Infectious Diseases|June 12, 2023
Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture-Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18-65 Years in 2019-2020Allison L Naleway, Sara S Kim, Brendan Flannery, et al.
Pageof 15